Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury

Terapevticheskii Arkhiv

Volumn 84, Issue 11, 2012, Pages 26-29

  Sukhanov, D S ^a  

^a NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

Author keywords

Ademethionine; Antituberculosis drugs; Drug induced hepatotoxicity; Laboratory severity index; Reamberine; Remaxol

Indexed keywords

DRUG DERIVATIVE; MEGLUMINE; PROTECTIVE AGENT; REAMBERIN; REMAXOL; S ADENOSYLMETHIONINE; SUCCINIC ACID DERIVATIVE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG COST; ECONOMICS; HUMAN; LUNG TUBERCULOSIS; NUMBERS NEEDED TO TREAT; PATHOLOGY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOXIC HEPATITIS; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; DRUG COSTS; DRUG-INDUCED LIVER INJURY; HUMANS; MEGLUMINE; NUMBERS NEEDED TO TREAT; PROTECTIVE AGENTS; RISK ASSESSMENT; S-ADENOSYLMETHIONINE; SEVERITY OF ILLNESS INDEX; SUCCINATES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84872027911     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Senaratne W.V., Pinidiyapathirage M.J., Perera G.A. et al. Antituberculosis drug induced gepatitis - a Sri Lankan experience. Ceylon Med J 2006; 51 (2): 9-14.
2. Introduction to biostatistics: Textbook. Vienna School of Clinical Research 2009